Kotak Institutional Equities has updated its large-cap model portfolio by adding SBI Life Insurance and TCS, with each receiving a 1.5% allocation. The brokerage also rebalanced its mid-cap holdings by including CRISIL and DCB Bank while exiting several stocks. These shifts reflect a strategic move toward companies with stronger earnings resilience.
Kotak Institutional Equities has revised its model portfolios, marking a strategic shift in its preferred stock list. In the large-cap segment, the brokerage has added SBI Life Insurance and Tata Consultancy Services (TCS), allocating 1.5% to each. The firm also increased its holding in construction major Larsen & Toubro, which now carries a 4% weightage. These changes highlight a preference for companies with stable balance sheets and predictable earnings growth.
In the mid-cap space, the firm introduced CRISIL and DCB Bank. The rebalancing also involved moving ICICI Prudential Life from the large-cap portfolio to the mid-cap category. Such adjustments are often used by institutional analysts to align portfolios with current sector trends or valuation assessments. For investors, these changes signal a move away from certain high-growth, high-valuation mid-cap names that have recently faced price pressure.
The brokerage also executed several exits and reductions to refine its risk exposure. Mankind Pharma was removed from the large-cap list, while weights in DLF and GMR Airports were reduced to 1.5% and 1.6% respectively. Within the mid-cap segment, the firm exited positions in Dixon Technologies, Dr Lal PathLabs, and Info Edge. These removals suggest a cautious stance on stocks where the risk-to-reward profile may have become less attractive at current price levels.
Investors tracking these changes should note that model portfolios are tactical views rather than direct trading recommendations. The effectiveness of these shifts depends on the underlying earnings growth of the selected companies and the broader performance of the financial and IT sectors. The primary monitorable for shareholders will be whether these new additions show the expected stability and growth in upcoming quarterly results, particularly as the brokerage emphasizes earnings quality over pure market momentum.